325 related articles for article (PubMed ID: 18159713)
1. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
Soen S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713
[No Abstract] [Full Text] [Related]
2. [Prevention of fractures with therapeutic agents for osteoporosis].
Hosoi T
Nihon Rinsho; 2004 Feb; 62 Suppl 2():596-601. PubMed ID: 15035197
[No Abstract] [Full Text] [Related]
3. [Treatment of osteoporosis: overview].
Nakamura T
Nihon Rinsho; 2002 Mar; 60 Suppl 3():273-9. PubMed ID: 11979919
[No Abstract] [Full Text] [Related]
4. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198
[No Abstract] [Full Text] [Related]
5. [Evidence of raloxifene on postmenopausal osteoporosis].
Okano H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():374-80. PubMed ID: 18161135
[No Abstract] [Full Text] [Related]
6. [Evidence of risedronate for treatment of osteoporosis].
Soen S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():344-7. PubMed ID: 18161128
[No Abstract] [Full Text] [Related]
7. [Evidence for efficacy of active vitamin D3 as an anti-osteoporotic drug].
Inoue D
Clin Calcium; 2008 Oct; 18(10):1469-75. PubMed ID: 18830044
[TBL] [Abstract][Full Text] [Related]
8. [A-TOP research group/JOINT-02].
Kuroda T; Ohta H; Shiraki M; Miyakawa N; Hosoi T; Nakamura T; Fukunaga M; Orimo H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():271-4. PubMed ID: 18161118
[No Abstract] [Full Text] [Related]
9. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
10. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
MMW Fortschr Med; 2003 Aug; 145(31-32):55. PubMed ID: 14524081
[No Abstract] [Full Text] [Related]
11. [Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].
Soen S
Nihon Rinsho; 2009 May; 67(5):985-90. PubMed ID: 19432121
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of primary osteoporosis in men].
Yamaguchi T; Sugimoto T
Clin Calcium; 2006 Mar; 16(3):474-9. PubMed ID: 16508131
[TBL] [Abstract][Full Text] [Related]
13. [Concurrent treatment of osteoporosis including vitamin K].
Kobayashi S; Shiraki M; Takaoka K
Clin Calcium; 2007 Nov; 17(11):1731-7. PubMed ID: 17982194
[TBL] [Abstract][Full Text] [Related]
14. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
Soen S
Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
Soen S
Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapeutic management of osteoprosis and osteopenia.
Alexander IM
Nurse Pract; 2009 Jun; 34(6):30-40; quiz 41. PubMed ID: 19474629
[No Abstract] [Full Text] [Related]
17. [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in clinical trials for osteoporosis in Japan].
Nakamura T
Clin Calcium; 2011 Dec; 21(12):145-51. PubMed ID: 22133833
[TBL] [Abstract][Full Text] [Related]
18. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
Ohta H
Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135
[TBL] [Abstract][Full Text] [Related]
19. [Absolute risk for fracture and WHO guideline. Pharmacological intervention to prevent osteoporotic fractures in the elderly].
Hosoi T;
Clin Calcium; 2007 Jul; 17(7):1098-104. PubMed ID: 17607078
[TBL] [Abstract][Full Text] [Related]
20. Latest innovation in the treatment of osteoporosis: SERMs and the role of parathyroid hormone.
Thiebaud D
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S124-5. PubMed ID: 21213508
[No Abstract] [Full Text] [Related]
[Next] [New Search]